China NMPA Product Recall - drill bit guide

Nobel Biocare AB, through its subsidiary Nobel Biocare Trading (Shanghai) Co., Ltd., initiated a voluntary Class III recall of certain drill guide devices. The recall, reported on February 21, 2023, by the National Medical Products Administration (NMPA), stems from a critical manufacturing issue involving the use of incorrect raw materials in specific models and batches of these medical devices. The primary concern is the potential impact of these substandard materials on the performance and safety of the drill guide devices. While specific adverse health consequences are not detailed, a Class III classification generally suggests a low probability of serious health implications. As a required action under the NMPA's regulatory framework, Nobel Biocare AB is undertaking a voluntary recall to remove the affected products from the market. This proactive measure aims to maintain product integrity and patient safety, with further details regarding affected product models, specifications, and batch numbers available in the official "Medical Device Recall Event Report Form" attachment.